Excitatory/Inhibitory Synaptic Imbalance Leads to Hippocampal Hyperexcitability in Mouse Models of Tuberous Sclerosis

Neuron

Volumn 78, Issue 3, 2013, Pages 510-522

  Bateup, Helen S ^a   Johnson, Caroline A ^a   Denefrio, Cassandra L ^a   Saulnier, Jessica L ^a   Kornacker, Karl ^b   Sabatini, Bernardo L ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; FOREBRAIN; GENE; HIPPOCAMPUS; HYPEREXCITABILITY; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; MOUSE; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TSC1 GENE; TUBEROUS SCLEROSIS; TUBEROUS SCLEROSIS COMPLEX MTOR SIGNALING PATHWAY; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MICE; MICE, KNOCKOUT; NERVE NET; SIGNAL TRANSDUCTION; SYNAPSES; TOR SERINE-THREONINE KINASES; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84877344739     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.03.017     Document Type: Article

References (47)

1. Auerbach B.D., Osterweil E.K., Bear M.F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011, 480:63-68.
2. Bateup H.S., Takasaki K.T., Saulnier J.L., Denefrio C.L., Sabatini B.L. Loss of Tsc1 invivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J.Neurosci. 2011, 31:8862-8869.
3. Bourgeron T. A synaptic trek to autism. Curr. Opin. Neurobiol. 2009, 19:231-234.
4. Chévere-Torres I., Kaphzan H., Bhattacharya A., Kang A., Maki J.M., Gambello M.J., Arbiser J.L., Santini E., Klann E. Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the δRG mouse model of tuberous sclerosis complex. Neurobiol. Dis. 2012, 45:1101-1110.
5. Cudmore R.H., Fronzaroli-Molinieres L., Giraud P., Debanne D. Spike-time precision and network synchrony are controlled by the homeostatic regulation of the D-type potassium current. J.Neurosci. 2010, 30:12885-12895.
6. Davis G.W. Homeostatic control of neural activity: from phenomenology to molecular design. Annu. Rev. Neurosci. 2006, 29:307-323.
7. de Vries P.J. Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. Neurotherapeutics 2010, 7:275-282.
8. Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., Ramesh V., Silva A.J. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat. Med. 2008, 14:843-848.
9. Gillberg C., Billstedt E. Autism and Asperger syndrome: coexistence with other clinical disorders. Acta Psychiatr. Scand. 2000, 102:321-330.
10. Hussman J.P. Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J.Autism Dev. Disord. 2001, 31:247-248.
11. Isaacson J.S., Scanziani M. How inhibition shapes cortical activity. Neuron 2011, 72:231-243.
12. Kelleher R.J., Bear M.F. The autistic neuron: troubled translation?. Cell 2008, 135:401-406.
13. Kelleher R.J., Geigenmüller U., Hovhannisyan H., Trautman E., Pinard R., Rathmell B., Carpenter R., Margulies D. High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism. PLoS ONE 2012, 7:e35003.
14. Kullmann D.M. Interneuron networks in the hippocampus. Curr. Opin. Neurobiol. 2011, 21:709-716.
15. Kwiatkowski D.J., Manning B.D. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 2005, 14 Spec No. 2:R251-R258.
16. Kwiatkowski D.J., Zhang H., Bandura J.L., Heiberger K.M., Glogauer M., el-Hashemite N., Onda H. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet. 2002, 11:525-534.
17. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
18. Lu W., Shi Y., Jackson A.C., Bjorgan K., During M.J., Sprengel R., Seeburg P.H., Nicoll R.A. Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron 2009, 62:254-268.
19. Marder E., Goaillard J.M. Variability, compensation and homeostasis in neuron and network function. Nat. Rev. Neurosci. 2006, 7:563-574.
20. McDaniel S.S., Wong M. Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neurosci. Lett. 2011, 497:231-239.
21. Meador K.J. The basic science of memory as it applies to epilepsy. Epilepsia 2007, 48(Suppl 9):23-25.
22. Meikle L., Talos D.M., Onda H., Pollizzi K., Rotenberg A., Sahin M., Jensen F.E., Kwiatkowski D.J. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J.Neurosci. 2007, 27:5546-5558.
23. Metz A.E., Spruston N., Martina M. Dendritic D-type potassium currents inhibit the spike afterdepolarization in rat hippocampal CA1 pyramidal neurons. J.Physiol. 2007, 581:175-187.
24. Mori K., Mori T., Toda Y., Fujii E., Miyazaki M., Harada M., Kagami S. Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex. Brain Dev. 2012, 34:478-486.
25. Morrison R.S., Wenzel H.J., Kinoshita Y., Robbins C.A., Donehower L.A., Schwartzkroin P.A. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J.Neurosci. 1996, 16:1337-1345.
26. Paluszkiewicz S.M., Martin B.S., Huntsman M.M. Fragile X syndrome: the GABAergic system and circuit dysfunction. Dev. Neurosci. 2011, 33:349-364.
27. Prather P., de Vries P.J. Behavioral and cognitive aspects of tuberous sclerosis complex. J.Child Neurol. 2004, 19:666-674.
28. Raab-Graham K.F., Haddick P.C., Jan Y.N., Jan L.Y. Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites. Science 2006, 314:144-148.
29. Ramocki M.B., Zoghbi H.Y. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 2008, 455:912-918.
30. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003, 2:255-267.
31. Shepherd J.D., Rumbaugh G., Wu J., Chowdhury S., Plath N., Kuhl D., Huganir R.L., Worley P.F. Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron 2006, 52:475-484.
32. Spence S.J., Schneider M.T. The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr. Res. 2009, 65:599-606.
33. Talos D.M., Sun H., Kosaras B., Joseph A., Folkerth R.D., Poduri A., Madsen J.R., Black P.M., Jensen F.E. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Ann. Neurol. 2012, 71:539-551.
34. Tavazoie S.F., Alvarez V.A., Ridenour D.A., Kwiatkowski D.J., Sabatini B.L. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 2005, 8:1727-1734.
35. Thiele E.A. Managing and understanding epilepsy in tuberous sclerosis complex. Epilepsia 2010, 51(Suppl 1):90-91.
36. Tsai P.T., Hull C., Chu Y., Greene-Colozzi E., Sadowski A.R., Leech J.M., Steinberg J., Crawley J.N., Regehr W.G., Sahin M. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 2012, 488:647-651.
37. Tsien J.Z., Chen D.F., Gerber D., Tom C., Mercer E.H., Anderson D.J., Mayford M., Kandel E.R., Tonegawa S. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 1996, 87:1317-1326.
38. Turrigiano G. Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu. Rev. Neurosci. 2011, 34:89-103.
39. Turrigiano G.G., Leslie K.R., Desai N.S., Rutherford L.C., Nelson S.B. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 1998, 391:892-896.
40. Waung M.W., Huber K.M. Protein translation in synaptic plasticity: mGluR-LTD, Fragile X. Curr. Opin. Neurobiol. 2009, 19:319-326.
41. Wong M., Crino P.B. mTOR and Epileptogenesis in developmental brain malformations. Jasper's Basic Mechanisms of the Epilepsies 2012, National Center for Biotechnology Information, Bethesda, MD. J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.).
42. Wong M., Ess K.C., Uhlmann E.J., Jansen L.A., Li W., Crino P.B., Mennerick S., Yamada K.A., Gutmann D.H. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann. Neurol. 2003, 54:251-256.
43. Yang S.B., Tien A.C., Boddupalli G., Xu A.W., Jan Y.N., Jan L.Y. Rapamycin ameliorates age-dependent obesity associated with increased mTOR signaling in hypothalamic POMC neurons. Neuron 2012, 75:425-436.
44. Young D.M., Schenk A.K., Yang S.B., Jan Y.N., Jan L.Y. Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism. Proc. Natl. Acad. Sci. USA 2010, 107:11074-11079.
45. Zeng L.H., Rensing N.R., Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J.Neurosci. 2009, 29:6964-6972.
46. Zhu P.J., Huang W., Kalikulov D., Yoo J.W., Placzek A.N., Stoica L., Zhou H., Bell J.C., Friedlander M.J., Krnjević K., et al. Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibition. Cell 2011, 147:1384-1396.
47. Zoghbi H.Y. Postnatal neurodevelopmental disorders: meeting at the synapse?. Science 2003, 302:826-830.